Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 88 member C (FAM88C), also called Lnc-PPRL or pterygium positively-related lncRNA (LOC102724238), is a cytoplasm-enriched long non-coding RNA identified as upregulated in pterygium, a proliferative and degenerative disease of the ocular surface. FAM88C/Lnc-PPRL promotes the proliferation, migration, and invasion of human pterygium epithelial cells by activating the PI3K/PDK1 and downstream Akt/mTOR signaling pathways. These findings suggest a functional role for FAM88C in the pathogenesis of pterygium and indicate its potential as a disease biomarker or future therapeutic target, though it is not presently an established therapeutic target in clinical settings[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 88 member C (FAM88C).